Prostate Cancer - Results from #80

Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. June 6, 2022

DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. June 6, 2022

Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. June 6, 2022

Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level. June 6, 2022

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up. June 6, 2022

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. June 3, 2022

Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations. June 3, 2022

Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy. June 3, 2022

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation. June 3, 2022

The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels. June 3, 2022

First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature. June 3, 2022

Epidemiology of Urological Cancers in Brazil: Trends in Mortality Rates Over More Than Two Decades. June 2, 2022

Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men. June 2, 2022

A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide. June 2, 2022

Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017. June 2, 2022

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race. June 2, 2022

Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Imp June 2, 2022

The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers. June 1, 2022

Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy. June 1, 2022

The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters. June 1, 2022

Page 5 of 1230

email news signup